Osteopore (ASX:OSXDA) - Stock Price, News & Analysis

OSXDA Stock Overview

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally.

About the company

OSXDA fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Risk Analysis

Earnings have declined by 26.4% per year over past 5 years

Does not have a meaningful market cap (A$7M)

Shares are highly illiquid

Does not have meaningful revenue (A$2M)

+ 1 more risk

Osteopore Limited Competitors

Visioneering Technologies

ASX:VTI

AU$6.9m

VIP Gloves

ASX:VIP

AU$2.4m

Lumos Diagnostics Holdings

ASX:LDX

AU$22.5m

Next Science

ASX:NXS

AU$58.4m

Price History & Performance

Summary of all time highs, changes and price drops for Osteopore
Historical stock prices
Current Share Price	AU$0.60
52 Week High	AU$0.60
52 Week Low	AU$0.30
Beta	0.49
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	71.43%

Recent updates

Shareholder Returns

	OSXDA	AU Medical Equipment	AU Market
7D	50.0%	2.1%	-0.7%
1Y	n/a	16.0%	17.1%

Return vs Industry: Insufficient data to determine how OSXDA performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how OSXDA performed against the Australian Market.

Price Volatility

Is OSXDA's price volatile compared to industry and market?
OSXDA volatility
OSXDA Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	9.9%
Market Average Movement	8.9%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.6%

Stable Share Price: OSXDA's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine OSXDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2018	n/a	Jing Lim	www.osteopore.com

Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects.

Osteopore Limited Fundamentals Summary

How do Osteopore's earnings and revenue compare to its market cap?
OSXDA fundamental statistics
Market cap	AU$6.66m
Earnings (TTM)	-AU$4.87m
Revenue (TTM)	AU$2.22m

3.0x

P/S Ratio

-1.4x

P/E Ratio

Is OSXDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OSXDA income statement (TTM)
Revenue	AU$2.22m
Cost of Revenue	AU$581.51k
Gross Profit	AU$1.64m
Other Expenses	AU$6.51m
Earnings	-AU$4.87m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.47
Gross Margin	73.78%
Net Profit Margin	-219.72%
Debt/Equity Ratio	269.1%

How did OSXDA perform over the long term?

See historical performance and comparison

Osteopore ASX:OSXDA Stock Report